Showing results (1351-1360 of 1,751) with videos related to

Sort By:
Pageof 176
BMC Cancer|April 25, 2015
A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapyShabbir M H Alibhai, Daniel Santa Mina, Paul Ritvo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end pointsD J Bloomfield, M D Krahn, T Neogi, et al.
JMIR Research Protocols|May 27, 2021
Predictive Monitoring-Impact in Acute Care Cardiology Trial (PM-IMPACCT): Protocol for a Randomized Controlled TrialJessica Keim-Malpass, Sarah J Ratcliffe, Liza P Moorman, et al.
Heart (British Cardiac Society)|May 31, 2019
Outcomes of untreated frequent premature ventricular complexes with normal left ventricular functionAndrea K Y Lee, Jason Andrade, Nathaniel M Hawkins, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2022
Mechanism by which T7 bacteriophage protein Gp1.2 inhibits Escherichia coli dGTPaseBradley P Klemm, Deepa Singh, Cassandra E Smith, et al.
CJC Open|July 22, 2022
A Cost-Utility Analysis of the Syncope: Pacing or Recording in The Later Years (SPRITELY) TrialMark Hofmeister, Robert S Sheldon, Eldon Spackman, et al.
JACC. Clinical Electrophysiology|February 25, 2022
Randomized Pragmatic Trial of Pacemaker Versus Implantable Cardiac Monitor in Syncope and Bifascicular BlockRobert Sheldon, Mario Talajic, Anthony Tang, et al.
BJU International|November 15, 2008
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancerAbbas H Panju, Henriette Breunis, Angela M Cheung, et al.
Stroke|July 10, 2020
High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined SourceJan F Scheitz, Guillaume Pare, Lesly A Pearce, et al.
Head & Neck|January 11, 2020
Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patientsMartin Khan, Sami S Khaznadar, Johannes Routila, et al.
Pageof 176